A multiple sclerosis medication is manufactured at the Biogen Idec plant in Cambridge, Massachusetts. Essdras M Suarez | The Boston Globe | fake pictures Check out the companies making headlines at noon on Monday Biogen: A Morgan Stanley analyst upgraded the biopharmaceutical company to overweight from underweight and forecast a …
Read More »